Download PDF
Drug Res (Stuttg) 2019; 69(01): 5-11
DOI: 10.1055/a-0637-8948
Review
© Georg Thieme Verlag KG Stuttgart · New York

Pharmacological Control of Complications Following to Third Molar Removal: Evidence Based on A Meta-Analysis

Mario Alberto Isiordia-Espinoza
1   Departamento de Clínicas, División de Ciencias Biomédicas, Centro Universitario de los Altos, Universidad de Guadalajara, Tepatitlán de Morelos, Jalisco, México
2   Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, SLP, México
,
Ronell Eduardo Bologna-Molina
3   Departamento de Investigación, Facultad de Odontología, Universidad de la República (UDELAR), Montevideo, Uruguay
,
Ycenna Ailed Hernández-Miramontes
4   Consultorio particular, Tepic, Nayarit
,
Juan Ramón Zapata-Morales
5   Departamento de Farmacia, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, México
,
Angel Jobsabad Alonso-Castro
5   Departamento de Farmacia, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, México
,
Flavio Martínez-Morales
2   Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, SLP, México
,
Sergio Sánchez-Enriquez
1   Departamento de Clínicas, División de Ciencias Biomédicas, Centro Universitario de los Altos, Universidad de Guadalajara, Tepatitlán de Morelos, Jalisco, México
,
Nicolás Addiel Serafín-Higuera
6   Facultad de Odontología, Universidad Autónoma de Baja California, Mexicali, Baja California, México
,
Guillermo Pérez-Cortez
6   Facultad de Odontología, Universidad Autónoma de Baja California, Mexicali, Baja California, México
,
Lorenzo Franco-de la Torre
1   Departamento de Clínicas, División de Ciencias Biomédicas, Centro Universitario de los Altos, Universidad de Guadalajara, Tepatitlán de Morelos, Jalisco, México
› Author Affiliations
Further Information

Publication History

received 26 March 2018

accepted 23 May 2018

Publication Date:
26 June 2018 (online)

Also available at
    Permissions and Reprints

Abstract

Aims The purpose of this meta-analysis was to evaluate the clinical efficacy of non-steroidal anti-inflammatory drugs and dexamethasone on the trismus, postsurgical pain, facial swelling, as well as the analgesic consumption after third molar surgery.

Material and Methods The reports were identified in the most important medical databases. Those studies that met the requirements were fully assessed according to the inclusion and exclusion criteria. The quality of each report was evaluated with the Oxford Quality Scale and using the Cochrane Collaboration’s risk of bias tool. Each meta-analysis was done using the technique of mean difference and 95% confidence intervals employing a random effects model with the Review Manager 5.3., from the Cochrane Library. Significant statistical difference was accepted when the p value was less than 0.05 on the test of overall effect (Z value).

Results Qualitative evaluation was done using the data of 330 patients extracted from seven articles and the quantitative assessment with data of 200 patients from three reports. It was not observed difference among non-steroidal anti-inflammatory drugs and dexamethasone in any of the clinical effectiveness indicators.

Conclusion The outcomes of our meta-analysis indicate that non-steroidal anti-inflammatory drugs and dexamethasone have good therapeutic effect for the management of inflammatory complications following to third molar surgery.

Key words

Non-steroidal Anti-inflammatory Drugs - Dexamethasone - Post-surgical Complications - Third Molar Surgery - Evidence-Based Dentistry
 

  • References

  • 1 Orozco-Solís M, García-Ávalos Y, Pichardo-Ramírez C. et al. Single dose of diclofenac or meloxicam for control of pain, facial swelling, and trismus in oral surgery. Med Oral Patol Oral Cir Bucal 2016; 21: e127-e134
    CrossrefPubMedGoogle Scholar
  • 2 Chen Q, Chen J, Hu B. et al. Submucosal injection of dexamethasone reduces postoperative discomfort after third-molar extraction: A systematic review and meta-analysis. J Am Dent Assoc. 2017; 148: 81-91
    CrossrefPubMedGoogle Scholar
  • 3 Costa FW, Soares EC, Esses DF. et al. A split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120 mg on inflammatory events following removal of unerupted mandibular third molars. Int J Oral Maxillofac Surg. 2015; 44: 1166-1174
    CrossrefPubMedGoogle Scholar
  • 4 Chugh A, Singh S, Mittal Y. et al. Submucosal injection of dexamethasone and methylprednisolone for the control of postoperative sequelae after third molar surgery: Randomized controlled trial. Int J Oral Maxillofac Surg. 2018; 47: 228-233
    CrossrefPubMedGoogle Scholar
  • 5 Moore PA, Brar P, Smiga ER. et al. Preemptive rofecoxib and dexamethasone for prevention of pain and trismus following third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: E1-E7
    CrossrefPubMedGoogle Scholar
  • 6 Campbell WI, Kendrick RW. Postoperative dental pain – a comparative study of anti-inflammatory and analgesic agents. Ulster Med J. 1991; 60: 39-43
    PubMedGoogle Scholar
  • 7 Claseman TS, Foley WL, Davis RD. et al. A clinical evaluation of the analgesic efficacy of preoperative administration of ketorolac and dexamethasone following surgical removal of third molars. Anesth Prog 1998; 45: 110-116
    PubMedGoogle Scholar
  • 8 Lima CAA, Favarini VT, Torres AM. et al. Oral dexamethasone decreases postoperative pain, swelling, and trismus more than diclofenac following third molar removal: a randomized controlled clinical trial. Oral Maxillofac Surg 2017; 21: 321-326
    CrossrefPubMedGoogle Scholar
  • 9 Paiva-Oliveira JG, Bastos PR, Cury Pontes ER. et al Comparison of the anti-inflammatory effect of dexamethasone and ketorolac in the extractions of third molars. Oral Maxillofac Surg 2016; 20: 123-133
    CrossrefPubMedGoogle Scholar
  • 10 Mehra P, Reebye U, Nadershah M. et al. Efficacy of anti-inflammatory drugs in third molar surgery: A randomized clinical trial. Int J Oral Maxillofac Surg. 2013; 42: 835-842
    CrossrefPubMedGoogle Scholar
  • 11 Simone JL, Jorge WA, Horliana AC. et al. Comparative analysis of preemptive analgesic effect of dexamethasone and diclofenac following third molar surgery. Braz Oral Res 2013; 27: 266-271
    CrossrefPubMedGoogle Scholar
  • 12 Sotto-Maior BS, Senna PM, de Souza Picorelli Assis NM. Corticosteroids or cyclooxygenase 2-selective inhibitor medication for the management of pain and swelling after third-molar surgery. J Craniofac Surg 2011; 22: 758-762
    CrossrefPubMedGoogle Scholar
  • 13 Hutton B, Salanti G, Caldwell DM. et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Ann Intern Med. 2015; 162: 777-784
    CrossrefPubMedGoogle Scholar
  • 14 Jadad AR, Moore RA, Carroll D. et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials 1996; 17: 1-12
    CrossrefPubMedGoogle Scholar
  • 15 Isiordia-Espinoza MA, Pozos-Guillén AJ, Aragon-Martinez OH. Analgesic efficacy and safety of single-dose tramadol and non-steroidal anti-inflammatory drugs in operations on the third molars: A systematic review and meta-analysis. Br J Oral Maxillofac Surg. 2014; 52: 775-783
    CrossrefPubMedGoogle Scholar
  • 16 Isiordia-Espinoza MA, Aragon-Martinez OH, Martínez-Morales JF. et al. Risk of wound infection and safety profile of amoxicillin in healthy patients which required third molar surgery: A systematic review and meta-analysis. Br J Oral Maxillofac Surg. 2015; 53: 796-804
    CrossrefPubMedGoogle Scholar
  • 17 Isiordia-Espinoza MA, Aragón-Martínez OH, Bollogna-Molina RE. et al. Infection, alveolar osteitis, and adverse effects using metronidazole in healthy patients undergoing third molar surgery: A Meta-analysis. J Maxillofac Oral Surg 2018; 17: 142-149
    CrossrefPubMedGoogle Scholar
  • 18 Higgins JP, Green S.(eds) (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration, Oxford. http://www.cochrane-handbook.org
    PubMed
  • 19 Sadeghirad B, Siemieniuk RAC, Brignardello-Petersen R. et al. Corticosteroids for treatment of sore throat: Systematic review and meta-analysis of randomized trials. BMJ 2017; 358: j3887
    PubMedGoogle Scholar
  • 20 Essex MN, Zhang RY, Berger MF. et al. Safety of celecoxib compared with placebo and non-selective NSAIDs: Cumulative meta-analysis of 89 randomized controlled trials. Expert Opin Drug Safety 2013; 12: 465-477
    CrossrefPubMedGoogle Scholar
  • 21 Bennett WM, Henrich WL, Stoff JS. The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations. Am J Kidney Dis. 1996; 28: S56-S62
    CrossrefPubMedGoogle Scholar
  • 22 Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: An update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013; 16: 821-847
    PubMedGoogle Scholar
  • 23 Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011; 128: 305-310
    CrossrefPubMedGoogle Scholar
  • 24 Loguercio AD, Maran BM, Hanzen TA. et al. Randomized clinical trials of dental bleaching – Compliance with the CONSORT Statement: a systematic review. Braz Oral Res 2017; 31: e60
    PubMedGoogle Scholar
  • 25 Rennie D. CONSORT revised: Improving the reporting of randomized trials. JAMA 2001; 285: 2006-2007
    CrossrefPubMedGoogle Scholar
  • 26 Schulz KF, Altman DG, Moher D. Group C. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials. BMC Med 2010; 8: 18
    CrossrefPubMedGoogle Scholar
  • 27 Moher D, Hopewell S, Schulz KF et al. CONSORT 2010 Explanation and elaboration: Updated guidelines for reporting parallel group randomized trials. BMJ. 2010; 340:
    PubMed